[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Haemophilus influenzae Type B Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 60 pages | ID: H45DEC2D8C96EN
VPAResearch

US$ 1,699.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Haemophilus influenzae Type B Infections Drug pipeline report- 2020 is an annual R&D review of Haemophilus influenzae Type B Infections pipeline candidates. The report presents the current status of all major Haemophilus influenzae Type B Infections therapeutic compounds. Detailed insights into Haemophilus influenzae Type B Infections pipeline development, current status, companies, drug profiles and Haemophilus influenzae Type B Infections preclinical and clinical trials are included.

2020 Haemophilus influenzae Type B Infections Pipeline Market Insights
Haemophilus influenzae Type B Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Haemophilus influenzae Type B Infections therapies, pipeline by phase and others are included.

Haemophilus influenzae Type B Infections pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Haemophilus influenzae Type B Infections Therapeutic Drug candidates
Both active and inactive Haemophilus influenzae Type B Infections pipeline drug candidates are included in the report

Haemophilus influenzae Type B Infections Clinical Trials and preclinical Studies
Haemophilus influenzae Type B Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Haemophilus influenzae Type B Infections pipeline market developments
Haemophilus influenzae Type B Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Haemophilus influenzae Type B Infections pipeline companies in active development
The report analyzes Haemophilus influenzae Type B Infections pipeline of the below companies-

Beijing Minhai Biotechnology Co Ltd, BIKEN Corp, Biological E Ltd, Cadila Healthcare Ltd, Changchun BCHT Biotechnology Co, Chongqing Zhifei Biological Products Co Ltd, Daiichi Sankyo Co. Ltd, GlaxoSmithKline Plc, Indian Immunologicals Ltd, Intravacc , LG Chem Ltd, Novo Medi Sciences Pvt Ltd, Olymvax Biopharmaceuticals Inc, Panacea Biotec Ltd, Tianjin CanSino Biotechnology Inc, Vaxxilon AG, Wockhardt Ltd

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
17 Companies investing in Haemophilus influenzae Type B Infections pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Haemophilus influenzae Type B Infections pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included
1. HAEMOPHILUS INFLUENZAE TYPE B INFECTIONS PIPELINE MARKET INSIGHTS, 2020

1.1 Haemophilus influenzae Type B Infections Disease Overview
1.2 Haemophilus influenzae Type B Infections Drug Pipeline Snapshot, 2020
  1.2.1 Haemophilus influenzae Type B Infections Pipeline Drugs by Phase
  1.2.2 Haemophilus influenzae Type B Infections Pipeline Drugs by Company
  1.2.3 Haemophilus influenzae Type B Infections Pipeline Drugs by Mechanism of Action
  1.2.4 Haemophilus influenzae Type B Infections Pipeline Drugs by Route of Administration

2. HAEMOPHILUS INFLUENZAE TYPE B INFECTIONS COMPANY WISE PIPELINE DETAILS

Beijing Minhai Biotechnology Co Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
BIKEN Corp Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biological E Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Cadila Healthcare Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Changchun BCHT Biotechnology Co Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Chongqing Zhifei Biological Products Co Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Daiichi Sankyo Co. Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Indian Immunologicals Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Intravacc Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
LG Chem Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Novo Medi Sciences Pvt Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Olymvax Biopharmaceuticals Inc Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Panacea Biotec Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Tianjin CanSino Biotechnology Inc Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Vaxxilon AG Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Wockhardt Ltd Haemophilus influenzae Type B Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. HAEMOPHILUS INFLUENZAE TYPE B INFECTIONS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. HAEMOPHILUS INFLUENZAE TYPE B INFECTIONS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts


More Publications